0001127602-24-014445.txt : 20240507 0001127602-24-014445.hdr.sgml : 20240507 20240507163754 ACCESSION NUMBER: 0001127602-24-014445 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240507 FILED AS OF DATE: 20240507 DATE AS OF CHANGE: 20240507 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Malik Fady Ibraham CENTRAL INDEX KEY: 0001551778 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50633 FILM NUMBER: 24922653 MAIL ADDRESS: STREET 1: 280 EAST GRAND AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CYTOKINETICS INC CENTRAL INDEX KEY: 0001061983 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 943291317 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 350 OYSTER POINT BOULEVARD STREET 2: . CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: (650) 624-3000 MAIL ADDRESS: STREET 1: 350 OYSTER POINT BOULEVARD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 form4.xml PRIMARY DOCUMENT X0508 4 2024-05-07 0001061983 CYTOKINETICS INC CYTK 0001551778 Malik Fady Ibraham 350 OYSTER POINT BLVD SOUTH SAN FRANCISCO CA 94080 1 EVP Research & Development 1 Common Stock 2024-05-07 4 M 0 14186 6.67 A 152603 D Common Stock 2024-05-07 4 S 0 14186 65.11 D 138417 D Common Stock 2024-05-07 4 S 0 1361 65.11 D 137056 D Incentive Stock Option (Right to Buy) 6.67 2024-05-07 4 M 0 14186 0 D 2016-03-23 2026-02-23 Common Stock 14186 0 D Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on September 26, 2023. /s/ John O. Faurescu, attorney-in-fact for Dr. Malik 2024-05-07